Abiochem Announces Cooperation with Tonghua Dongbao on a Generic Version of Sitagliption

SHANGHAI, September 26, 2021 - Abiochem has cooperated with a leading diabetes company，Tonghua Dongbao Pharmaceutical Co., Ltd. （600867.SH) to produce a generic version of Sitagliptin, and gets approved by CDC (Chinese Center for Disease Control and Prevention) recently. This drug is the first domestic generic drug manufactured based on "non-hydrolase" biosynthetic methods, opening up a new chapter in biosynthetic pharmaceuticals.